Silence Therapeutics plc Common Stock, Value, Issued
Silence Therapeutics plc (SLN) had Common Stock, Value, Issued of $10.29 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-10
- 2026-06-30: Common Stock, Value, Issued $10.29M.
- 2026-03-31: Common Stock, Value, Issued $10.29M.
- 2025-12-31: Common Stock, Value, Issued $10.29M.
- 2025-09-30: Common Stock, Value, Issued $10.29M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $10.29M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $10.29M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $10.29M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $10.29M 10-Q · filed 2026-05-07 |
| 2025-06-30 | $10.29M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.29M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.29M 10-K · filed 2026-03-05 |
| 2023-12-31 | $8.85M 10-K · filed 2025-02-27 |
| 2022-12-31 | $8.15M 10-K · filed 2025-02-27 |